SV Life Sciences Fund VI, L.P.
CIK 1642251 · last filed 2019-01-18
SV Life Sciences Fund VI, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for AVRO, was dated Jan 18, 2019. The firm reports its address in Boston, MA. 6 SEC filings were submitted jointly with SV Life Sciences Fund VI Strategic Partners, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
2
$0
Filer Profile
ONE BOSTON PLACE, SUITE 3900
BOSTON, MA 02108
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (AVRO) Delisted | 10%+ Owner | 155,566 | $16.80 | $2.61M | $0 | 2 | 2019-01-18 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-18 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Other (J) | −3,221,292 | $0 | EDGAR |
| 2018-06-25 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Conv (C) | +10,944,108 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.